SynthesisPediatric research2026
Persistent dysregulated inflammation in cerebral palsy: a systematic review.
Synthesis in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSystemic inflammation in the perinatal period has been linked to cerebral palsy (CP), with recent studies indicating that this inflammation persists into childhood and beyond. This systematic review investigates persistent dysregulated inflammation in CP and explores potential therapeutic targets.
methodsThis systematic review adhered to PRISMA guidelines. Using specific key words, we extracted studies from multiple databases on 27th February 2024 (including PubMed, Cochrane Library, Embase, "Neuroscience journal" published by Science Direct, and Ovid). The quality of evidence was assessed with the Newcastle-Ottawa Scale. Relevant data was extracted to a Google Sheets spreadsheet for analysis.
findings1064 studies were identified, 17 were included. Of these studies, 10 found elevated levels of cytokines and immune cells in children with CP compared to controls. Persistent inflammation in CP was associated with elevated levels of cytokines (TNF-α, IL-1β, IL-6, and IL-10) and higher baseline levels of certain immune cells. Commonly assessed biomarkers included TNF-α, IL-6, IL-10, and IL-8, with persistent inflammation observed in blood, saliva, CSF, and muscle samples. Potential therapeutic targets include magnesium sulphate, melatonin, immunotherapy, and stem cell treatments. CORRELATION WITH DISEASE SEVERITY: Persistent inflammation in CP has been shown to correlate with disease severity, particularly higher gross motor function classification system (GMFCS) scores, across CP subtypes.
interpretationThis systematic review indicates that inflammation persists beyond the perinatal period in cerebral palsy. However, Future consensus required to minimise sample and biomarker heterogeneity, variability in reported aetiologies and small sample sizes which confound conclusions and to identify universal therapeutic targets. IMPACT: Patients with CP had inflammation that persisted into childhood compared to controls Elevated inflammation may correlate with disease severity in CP Persistent inflammation in CP is a potential therapeutic target Lack of standardised consensus definition and classification of CP across many studies.
Identifiers
42624884What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.